PharmaBoardroom - TEVA
Israel's Teva buys part of Allergan drug company for $40.5 billion | The Times of Israel
Teva stocks fall after company said named in US price-fixing drug 'cartel' probe | The Times of Israel
Teva Restructuring Coming Together, Rebuilding Confidence in the Company | BioSpace
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/VOJDCVZUMRC4JJCHAKWYUMXZSE.jpg "FDA approves a generic version of Teva Pharmaceutical's best-selling drug; company shares tumble")
FDA approves a generic version of Teva Pharmaceutical's best-selling drug; company shares tumble
Teva to pay NIS 75 million to Israel authorities to settle foreign bribe claims | The Times of Israel
Teva to Pay California $69 Million in Narcolepsy Drug Settlement | Ctech
Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva should ditch generics, focus on branded drugs, activist investor says | The Times of Israel
Teva Becomes First Pharmaceutical Company to Execute Sustainability-linked Bond Tied to both Climate and Access to Medicine Targets | Business Wire
Patients Eagerly Awaited a Generic Drug. Then They Saw the Price. - The New York Times
Drug-maker Teva fueled opioid addiction in NY, jury finds | Business Insurance
Teva recalls U.S.-made drugs following contamination fears | Pittsburgh Post-Gazette
Teva sheds logistics center for $127M after 2 about-faces | Fierce Pharma
Teva Faces Rocky Path to Recovery After Debt | Fortune
Teva to Pay $85 Million Settlement in Oklahoma Opioid Case | Time
Omeprazole Generic Drug Box by Teva Closeup Against White Editorial Stock Photo - Image of medical, gastroesophageal: 187163353
Teva Pharmaceutical's US Arm Charged With Price-Fixing
Teva pharmaceuticals Stock Photo - Alamy
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceutical CEO says health-care is facing 'huge disruption'
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
